Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-02-17Clinical Trial Update: Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome
A clinical trial from Shandong University exploring the relationship between confocal laser endomicroscopy features and the gastric mucosal …
-
FDA approval · 2014-02-05FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride, a combination therap…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection [Phase 4]
This update reports the completion of a Phase 4 trial comparing standard-dose versus half-dose quadruple therapy (rabeprazole, clarithromyci…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection [NA]
This clinical trial update notes that a study evaluating the additive effect of Endonase on eradication rates for second-line Helicobacter p…
-
CLINICAL_TRIALS research · 2014-01-01Clinical Trial Update: Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use [Phase 4]
A prospective Phase 4 clinical trial evaluating Helicobacter pylori eradication therapy in relation to past antibiotic use.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-19FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing updates to the approved generic product.
-
FDA label_change · 2013-12-10FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) to update the product labeling. The sponsor is Wy…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Quadruple and Phytomedicine-based Therapies in H. Pylori Infection [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating quadruple therapy and phytomedicine-based treatments for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication [Phase 4]
Phase 4 study comparing high-dose dual therapy, sequential therapy, and triple therapy for Helicobacter pylori eradication has completed.
-
FDA approval · 2013-11-08FDA Approved: RABEPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for generic rabeprazole sodium, a proton pump inhibitor indicated for ga…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Molecular Detection of Antibiotic Resistance and H Pylori Eradication [NA]
This clinical trial update describes completion of a study on molecular detection of antibiotic resistance in Helicobacter pylori and approa…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori [Phase 3]
Phase 3 trial evaluating vonoprazan (TAK-438) with amoxicillin and clarithromycin as first-line therapy for Helicobacter pylori infection; s…
-
FDA approval · 2013-10-31FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
The FDA approved a supplemental application for omeprazole magnesium from Gericare Pharmaceuticals, granting approval for a generic product …
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy [Phase 4]
A Phase 4 trial compares 14-day clarithromycin-based triple therapy with a 10-day sequential therapy as first-line regimens for Helicobacter…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori [Phase 4]
This Phase 4 clinical trial update reports on the efficacy and safety of probiotic therapy as supportive treatment during Helicobacter pylor…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Clarithromycin Resistant Tailored Therapy [Phase 4]
Phase 4 trial results update on clarithromycin-resistant tailored therapy for Helicobacter pylori infection in peptic ulcer disease; results…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors [Phase 3]
A Phase 3 clinical trial evaluating Lactobacillus reuteri ProGastria in adults with Helicobacter pylori infection on proton pump inhibitors …
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection [NA]
A completed clinical trial showing equivalence of a modified BreathID test to the currently approved BreathID for detecting Helicobacter pyl…
-
FDA approval · 2013-08-27FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc., resulting in approval of a generic Lansoprazol…
-
FDA approval · 2013-08-14FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental NDA for a bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride product (NDA 050786) from …
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Eradication Rates of Helicobacter Pylori and Its Affecting Factors
The clinical trial update reports the eradication rates of Helicobacter pylori infection and the factors affecting treatment success.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea [Phase 4]
Phase 4 trial update describing a 15-day sequential therapy for Helicobacter pylori infection conducted in Korea; study status is completed.
-
FDA approval · 2013-08-06FDA Approved: ESOMEPRAZOLE STRONTIUM — Original Application (R2 Pharma, LLC)
FDA approved esomeprazole strontium via the Original Application (NDA202342) for indications consistent with proton pump inhibitors (GERD-re…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults [Phase 1]
Phase 1 study reports safety and immunogenicity data for an investigational Helicobacter pylori vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori [Phase 4]
Phase 4 trial evaluating clarithromycin-based bismuth quadruple therapy for Helicobacter pylori infection in patients with functional dyspep…